BONUS!!! Download part of Lead2PassExam ACNS dumps for free: https://drive.google.com/open?id=1QrwtaQsRDBU18-gnMSIXgGJGMNTYY8-X
Nowadays, we live so busy every day. Especially for some businessmen who want to pass the ACNS exam and get related certification, time is vital importance for them, they may don’t have enough time to prepare for their exam. Some of them may give it up. But our ACNS guide tests can solve these problems perfectly, because our study materials only need little hours can be grasped. Once you use our ACNS Latest Dumps, you will save a lot of time. High effectiveness is our great advantage. After twenty to thirty hours’ practice, you are ready to take the real ACNS exam torrent. The results will never let you down. You just need to wait for obtaining the certificate.
| Section | Objectives |
|---|---|
| Topic 1: Evidence-Based Practice and Research | - Translation of research into clinical practice
|
| Topic 2: Patient and Family Outcomes Management | - Care coordination and chronic disease management
|
| Topic 3: Systems Leadership and Quality Improvement | - Healthcare systems improvement
|
| Topic 4: Clinical Judgment and Advanced Practice Nursing | - Comprehensive health assessment and differential diagnosis
|
| Topic 5: Professional Role Development | - Advanced practice nursing roles and ethics
|
>> ACNS Free Test Questions <<
Our ACNS practice questions and answers are created according to the requirement of the certification center and the latest exam information. Our ACNS real dumps cover the comprehensive knowledge points and latest practice materials that enough to help you Clear ACNS Exam tests. You will get our valid ACNS dumps torrent and instantly download the exam pdf after payment.
NEW QUESTION # 10
You are treating your patient with a 5HT4 agonist for his gastrointestinal disorder. Of the following, which would you prescribe?
Answer: D
Explanation:
To address the question of which medication to prescribe for a patient's gastrointestinal disorder using a 5HT4 agonist, it is essential to understand the pharmacological role of each option listed. Here is an expanded explanation of the drug choices provided:
Tegaserod: This medication is a 5HT4 agonist and is used specifically to treat certain gastrointestinal disorders, particularly those associated with symptoms of irritable bowel syndrome (IBS) predominantly featuring constipation. Tegaserod works by enhancing the release of neurotransmitters that increase the movement of the intestines, thereby promoting bowel movements and alleviating constipation. Due to its mechanism of action targeting the 5HT4 receptor, tegaserod is the correct choice when a 5HT4 agonist is indicated for gastrointestinal issues.
Senna: Senna is categorized as a stimulant laxative. It operates by stimulating the muscles in the intestines, which helps to facilitate the movement of stool through the bowel. Though effective for constipation, Senna does not function as a 5HT4 agonist and therefore does not fit the requirement for the medication needed in this scenario.
Cisapride: Previously used as a promotility agent, Cisapride enhances the release of acetylcholine at the myenteric plexus, which stimulates gastrointestinal motility and accelerates gastric emptying. It acts on serotonin receptors, but its primary action is not on the 5HT4 receptor. Furthermore, due to concerns about serious cardiac side effects, its availability is highly restricted in many countries.
Alosetron: This medication is a 5HT3 antagonist used primarily to manage severe diarrhea-predominant irritable bowel syndrome (IBS) in women. By blocking the 5HT3 receptors, alosetron slows the movement of stools through the intestines, which is the opposite effect of what is typically desired with a 5HT4 agonist. Therefore, alosetron is not suitable for the requirement of a 5HT4 agonist.
In conclusion, for a patient needing a 5HT4 agonist for treating a gastrointestinal disorder, Tegaserod is the appropriate prescription among the options listed. It directly targets the 5HT4 receptors and is effective in enhancing gut motility, specifically in cases related to constipation-predominant IBS. Other drugs listed either do not target the 5HT4 receptor or have different primary indications and mechanisms of action that do not align with the therapeutic needs specified.
NEW QUESTION # 11
A 52-year old female is in the office with a new-onset of reflux esophagitis. You are assessing her and asking pertinent questions. What do you expect to find with her that would support this diagnosis?
Answer: C
Explanation:
When assessing a 52-year-old female patient presenting with new-onset reflux esophagitis, certain findings in her medical history and symptoms can support the diagnosis. Here are the pertinent factors to consider:
**Recent Initiation of Estrogen-Progestin Hormonal Therapy**: This is a significant factor to explore. Medications can impact the function of the gastrointestinal system, particularly the lower esophageal sphincter (LES). The LES is a critical barrier preventing the backflow of stomach contents, including acid, into the esophagus. Estrogen and progestin, components of many hormonal therapies, are known to potentially decrease LES pressure. This reduction in pressure can lead to or exacerbate gastroesophageal reflux disease (GERD), presenting as reflux esophagitis. Asking about the timing of hormonal therapy initiation and correlating it with the onset of reflux symptoms can provide valuable diagnostic insight.
**Symptoms Consistent with Reflux Esophagitis**: The patient may report classic symptoms such as heartburn, regurgitation of food or sour liquid, and chest pain. Additionally, symptoms like difficulty swallowing (dysphagia), a sensation of a lump in the throat, and chronic cough might also be present. These symptoms often worsen after eating, when lying down, or bending over.
**Lifestyle and Dietary Factors**: Inquiring about recent changes in diet, alcohol consumption, smoking habits, and body weight can be helpful. Increased intake of fatty foods, alcohol, caffeine, and smoking are known risk factors for GERD. Obesity also contributes to increased abdominal pressure, which can promote the reflux of acid into the esophagus.
**Active H. pylori Infection**: While Helicobacter pylori infection is primarily associated with gastritis and peptic ulcer disease, it can indirectly influence the development of reflux esophagitis. The infection can lead to changes in the stomach lining and potentially affect acid production and gastric emptying, which might exacerbate reflux symptoms.
**Exclusion of Other Causes**: It is also crucial to rule out other potential causes of the patient's symptoms. For instance, a report of melena (black, tarry stools) might suggest gastrointestinal bleeding, which requires immediate attention and a different diagnostic pathway. Similarly, symptoms like recent weight loss and fatigue might necessitate a broader investigation to rule out other systemic conditions. By exploring these aspects during the patient interview and examination, a more comprehensive understanding of the potential cause of the reflux esophagitis can be achieved, guiding appropriate management and treatment strategies.
NEW QUESTION # 12
The Adult Clinical Nurse Specialist is seeing a 66-year old woman with well controlled hypertension. She finds that this patient is taking hydrochlorothiazide and has ad a 3 day history of a unilateral throbbing headache. She cannot chew because it increases the pain. Her physically exam is unremarkable except for a tender, incompressible right temporal artery. Her vital signs are normal. What is her diagnosis?
Answer: D
Explanation:
The correct diagnosis for the patient described is giant cell arteritis (GCA), also known as temporal arteritis. This condition is an important consideration due to the patient's age, symptoms, and examination findings. Giant cell arteritis is a form of vasculitis that predominantly affects older adults, typically those over the age of 50.
The key symptoms prompting consideration of GCA in this patient include a new, unilateral, throbbing headache and pain upon chewing (jaw claudication). These symptoms reflect the typical inflammatory process associated with GCA that affects the blood vessels supplying the scalp and muscles involved in mastication. The tenderness and incompressibility of the temporal artery on physical examination are classic signs of this disease. These physical signs are indicative of inflammation and possible thickening of the arterial walls, which can be palpable as a tender, hardened, or cord-like structure along the temple.
Additionally, while the patient's hypertension is well-controlled and might not directly relate to her current symptoms, it's important to consider that systemic vascular issues are more prevalent in patients with long-term hypertension. This background could indirectly increase the susceptibility or mask some symptoms of vascular inflammatory conditions like GCA.
The importance of timely diagnosis and treatment of giant cell arteritis cannot be overstated. If left untreated, GCA can lead to serious complications such as irreversible vision loss due to involvement of the arteries that supply the optic nerve. The typical treatment involves high-dose corticosteroids, which can significantly alleviate symptoms and prevent complications if started early.
In conclusion, the symptoms of a persistent, severe headache localized to one side of the head, jaw pain during mastication, and a tender, incompressible temporal artery in an elderly patient strongly point towards a diagnosis of giant cell arteritis. Immediate further investigation, typically including blood tests like the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), and potentially a temporal artery biopsy, is warranted to confirm the diagnosis and commence appropriate treatment.
NEW QUESTION # 13
Of the following which is a promotility agent you'd prescribe for your patient's gastrointestinal disorder?
Answer: C
Explanation:
To answer the question about which drug is a promotility agent that could be prescribed for a patient's gastrointestinal disorder, it is essential to understand what each listed medication is typically used for and how they function.
**Metoclopramide:** This is the correct answer to the question. Metoclopramide is a well-known promotility agent used primarily to treat nausea, vomiting, and gastroparesis (delayed gastric emptying). It works by enhancing the motility of the stomach and intestines, which helps speed the movement of food through the gastrointestinal tract. It acts by blocking dopamine receptors and increasing the release of acetylcholine in the gut, which stimulates gastric motility and accelerates gastric emptying. It's often prescribed under the brand name Reglan.
**Senna:** This is not a promotility agent but rather a stimulant laxative. Senna works by irritating the lining of the bowel, which causes a laxative effect. It is primarily used to treat constipation and to clear the bowel before diagnostic tests such as colonoscopy. Senna does not enhance the motility of the upper gastrointestinal tract and thus is not useful as a promotility agent.
**Tegaserod:** This medication is a selective 5-HT4 receptor agonist that was used to treat irritable bowel syndrome (IBS) with constipation and chronic idiopathic constipation. It works by mimicking the action of serotonin at the 5-HT4 receptor, enhancing peristaltic reflex and intestinal secretion, which helps increase gastrointestinal motility. However, it is not typically classified as a promotility agent like Metoclopramide, and its use has been limited due to concerns over cardiovascular side effects.
**Alosetron:** This drug is a selective 5-HT3 receptor antagonist used primarily for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women. Alosetron works by blocking serotonin receptors in the gastrointestinal tract, reducing bowel motility, and enhancing absorption. It effectively manages symptoms of IBS but does not promote motility; rather, it slows it down in cases of diarrhea-predominant IBS.
In conclusion, among the options provided, Metoclopramide is the only appropriate promotility agent for treating gastrointestinal disorders that involve delayed gastric emptying or reduced motility. The other listed drugs serve different purposes and act through mechanisms that do not enhance gastrointestinal motility in the way promotility agents like Metoclopramide do.
NEW QUESTION # 14
You are providing care to a patient who has had CABG. Two days post-surgery, she begins vomiting and complains of abdominal pain. What is the appropriate intervention for this patient?
Answer: C
Explanation:
The appropriate intervention for a patient who has had Coronary Artery Bypass Grafting (CABG) and begins to show symptoms of vomiting and abdominal pain two days post-surgery is to notify her doctor immediately so she can be assessed for gastrointestinal (GI) bleeding. This action is imperative because, although GI complications are infrequent following CABG-occurring in about 2% of cases-they can be severe and potentially life-threatening.
GI complications after CABG, such as bleeding, can arise from various sources including stress-related mucosal disease, peptic ulcers, or ischemic bowel disease. These conditions can lead to significant morbidity if not promptly diagnosed and treated. The symptoms of GI complications, including abdominal pain, distention, and nausea, necessitate urgent medical evaluation to rule out these serious conditions.
It is not advisable to merely administer anti-nausea medication and attempt to make the patient comfortable without further assessment. While managing symptoms is important, it is crucial to address the underlying cause to prevent complications. Similarly, reassuring the patient that this is normal without a proper assessment could delay necessary treatment and worsen the patient's condition.
Changing the patient's diet back to clear liquids, if she has progressed to full liquids, might seem like a cautious approach, but it does not address the potential severity of the underlying issue. This measure should only be considered following a thorough evaluation and under the guidance of a physician.
In conclusion, the initial step should always be to notify the patient's doctor for an immediate assessment when symptoms suggestive of GI complications arise post-CABG. This ensures that any serious conditions are promptly identified and managed, thereby reducing the risk of severe outcomes.
NEW QUESTION # 15
......
In order to meet a wide range of tastes, our company has developed the three versions of the ACNS preparation questions, which includes PDF version, online test engine and windows software. According to your own budget and choice, you can choose the most suitable one for you. And if you don't know which one to buy, you can free download the demos of the ACNS Study Materials to check it out. The demos of the ACNS exam questions are a small part of the real exam questions.
ACNS Quiz: https://www.lead2passexam.com/Nursing/valid-ACNS-exam-dumps.html
2026 Latest Lead2PassExam ACNS PDF Dumps and ACNS Exam Engine Free Share: https://drive.google.com/open?id=1QrwtaQsRDBU18-gnMSIXgGJGMNTYY8-X